Literature DB >> 12746705

[Peripheral neurotomies for the treatment of focal spasticity of the limbs].

P Decq1.   

Abstract

Introduced by Stoffel in 1912 for the treatment of spastic equinus foot, selective fascicular neurotomy consists in a partial section of the motor collaterals of the muscles presenting excessive spasticity. This peripheral surgery for spasticity is based on two main concepts: 1) Spinal reflexes and muscles are heterogeneous and have a regional organization depending on their role during normal movements. This is the physiological base of focal spasticity and peripheral treatment. 2) There is a differential re-innervation after a partial section, leading to motor recovery without spindles reinnervation (therefore without spasticity). Before performing neurotomies, a careful clinical assessment is required: what kind of spasticity? For what kind of goal (functional or comfort)? The surgery effects can be mimicked by motor nerve blocks (anesthetic drugs) to give to the patient an idea of the expected result. There are many neurotomies, depending on the clinical status, either in the lower or the upper limb. The most frequent is tibial neurotomy for spastic equinus foot.

Entities:  

Mesh:

Year:  2003        PMID: 12746705

Source DB:  PubMed          Journal:  Neurochirurgie        ISSN: 0028-3770            Impact factor:   1.553


  3 in total

1.  Long-term results of microsurgical selective tibial neurotomy for spastic foot : comparison of adult and child.

Authors:  Jong-Hoon Kim; Jae-Il Lee; Min-Su Kim; Seong-Ho Kim
Journal:  J Korean Neurosurg Soc       Date:  2010-04-30

2.  Anatomy and surgical landmarks for the ansa pectoralis: application to pectoralis major nerve selective neurotomy.

Authors:  Maud Creze; Johann Peltier; Eric Havet; Arnaud Potier; Michel Lefranc; Pascal Foulon; Daniel Le Gars
Journal:  Surg Radiol Anat       Date:  2012-07-28       Impact factor: 1.246

Review 3.  Selective peripheral neurotomy (SPN) for spasticity in childhood.

Authors:  M P Sindou; F Simon; P Mertens; P Decq
Journal:  Childs Nerv Syst       Date:  2007-06-29       Impact factor: 1.475

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.